Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
07/02/2003 | CN1427824A Indole derivatives, process for preparation of same and use thereof |
07/02/2003 | CN1427823A Pyrrolecarboxamides and pyrrolethioamides as fungicides |
07/02/2003 | CN1113060C Substituted 2-amino-4-alkylamino-1,3,5-triazine as herbicide |
07/02/2003 | CN1113059C Pipeazino derivatives as neurokinin antagonists |
07/01/2003 | US6586606 Process for the preparation of 3-aryl-benzofuran-2-ones |
07/01/2003 | US6586603 Forming 4-(5-(4-chlorophenyl)-3-trifluoromethyl)-1H-pyrazol-1 -yl)benzenesulfonamide used as antiinflammatory agents; side effect reduction |
07/01/2003 | US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
07/01/2003 | US6586448 Cholesteryl ester transfer protein inhibitors used as antilipemic agents for prophylaxis of cardiovascular disorders |
07/01/2003 | US6586447 Farnesyl protein transferase inhibitors such as 4-(6-(4-Cyano -phenyl)-3,3-bis-(1H-imidazol-4-ylmethyl)-2-oxo-2,3- dihydro-indol-1-ylmethyl)-N,N-dimethyl benzenesulfonamide used as anticarcinogenic agents |
07/01/2003 | US6586441 Adenosine receptor ligands and their use in the treatment of disease |
07/01/2003 | US6586434 Method for the preparation of tetrahydrobenzothiepines |
07/01/2003 | US6586431 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
07/01/2003 | US6586368 Condensed heterocylic compounds and herbicides containing them |
06/26/2003 | WO2003051878A1 Quinolinones as prostaglandin receptor ligands |
06/26/2003 | WO2003051870A1 Novel compounds |
06/26/2003 | WO2003051869A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
06/26/2003 | WO2003051866A1 2-guanidino-4-heterocyclylquinazolines |
06/26/2003 | WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS |
06/26/2003 | WO2003051847A1 (1-h-indazol-3-yl) -amide derivatives as gsk-3 inhibitors |
06/26/2003 | WO2003051846A2 Substituted phenyl derivatives |
06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/26/2003 | WO2003051825A1 Human adam-10 inhibitors |
06/26/2003 | WO2003051368A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
06/26/2003 | WO2003051366A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
06/26/2003 | WO2003051359A1 Cis-2,4,5- triphenyl-imidazolines and their use in the treatment of tumors |
06/26/2003 | WO2003051358A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
06/26/2003 | WO2003051306A2 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
06/26/2003 | WO2003051276A2 Therapeutic heterocycles |
06/26/2003 | WO2003051275A2 Benzodiazepine derivatives, preparation thereof and use thereof |
06/26/2003 | WO2003051274A2 Benzodiazepine derivatives, preparation thereof and use thereof |
06/26/2003 | WO2003040109A3 Quinazoline derivatives as antitumor agents |
06/26/2003 | US20030120096 Reacting racemic beta-lactam with lithium- 7-protected baccatin III- complex to form 3'desphenyl-3'-(1-napthyl)taxol; antitumor agents |
06/26/2003 | US20030120094 For improved binding of CB1/CB2 receptors; side effects reduction |
06/26/2003 | US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants |
06/26/2003 | US20030119895 Anticancer agents |
06/26/2003 | US20030119878 A 1-arylalkyl-3-aminoalkyl-1,4-dihydropyrid-4-one derivative; sexual disorders; anticarcinogenic agents; benign prostatic hypertrophy/fibroids of the uterus; endometriosis, polycystic ovarian disease, precocious puberty; contraceptives |
06/26/2003 | US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis |
06/26/2003 | US20030119868 Gyrase inhibitors and uses thereof |
06/26/2003 | US20030119852 Pyridine or pyrimidine compounds containing C(=O or =S)-N-S(O)m=o,1,2 group, used as insecticides, fungicides, miticides and parasiticides |
06/26/2003 | US20030119845 4-((4-benzyl(or methyl heteroaryl)-,1-piperazinyl)(8-quinolinyl)methyl)-N,N-diethylbenzamide or salt, useful for pain treatment |
06/26/2003 | US20030119836 Cyclooxygenase inhibitors |
06/26/2003 | US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds |
06/26/2003 | US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
06/26/2003 | US20030119816 Cycline-dependent kinase protein inhibitors; antiproliferative agents |
06/26/2003 | US20030119811 Ion channel antagonists that are NMDA antagonists; treatment of migraine, depression, anxiety, schizophrenia, Parkinson's disease, or stroke. |
06/26/2003 | US20030119810 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
06/26/2003 | US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors |
06/26/2003 | US20030119754 Treating respiratory syncytial virus and human parainfluenza virus infections |
06/26/2003 | US20030119749 Novel compounds possessing antibacterial, antifungal or antitumor activity |
06/26/2003 | US20030119670 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof |
06/26/2003 | US20030118924 Radiation transparent substrate; optical recording media |
06/26/2003 | CA2473938A1 Human adam-10 inhibitors |
06/26/2003 | CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives |
06/26/2003 | CA2470616A1 Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
06/26/2003 | CA2470276A1 Substituted phenyl derivatives |
06/26/2003 | CA2470214A1 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
06/26/2003 | CA2470030A1 2-guanidino-4-heterocyclylquinazolines |
06/26/2003 | CA2469048A1 Quinolinones as prostaglandin receptor ligands |
06/26/2003 | CA2468978A1 Therapeutic heterocycles |
06/26/2003 | CA2468448A1 Benzodiazepine derivatives, preparation thereof and use thereof |
06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
06/25/2003 | EP1320520A1 Sulfonylguanidine |
06/25/2003 | EP1320366A1 Substituted piperidines as melanocortin receptor agonists |
06/25/2003 | EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
06/25/2003 | EP1025086B1 Benzamidine derivatives as factor xa inhibitors |
06/25/2003 | EP0966282B1 Use of the angiotensin ii antagonists losartan and exp-3174 to treat symptomatic heart failure |
06/25/2003 | EP0946546B1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine |
06/25/2003 | EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides |
06/25/2003 | CN1426407A N-(heterocyclic)-benzene or pyridine sulphozmides as antithrombotic agents and anticoagulants |
06/25/2003 | CN1426405A 新型环状酰胺衍生物 Novel cyclic amide derivative |
06/25/2003 | CN1426395A Inhibitors of dipeptidyl peptidase IV |
06/25/2003 | CN1426391A Polyamine analogues as cytotoxic agents |
06/25/2003 | CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF) |
06/24/2003 | US6584266 Dicyanomethylenedihydrofuran compounds and polymer pendant groups having electron withdrawing groups and bivalent cyclic bridges |
06/24/2003 | US6583179 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone |
06/24/2003 | US6583166 Fewer side effects than D2 receptor antagonist neuroleptics; cardiovascular, kidney, central nervous system disorders; 3-(3-((4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)sulfanyl) propyl)-1,3,3a,4,5,9b-hexahydro-2H-benzo(e)indol-2-one |
06/24/2003 | US6583156 Particularly adenosine A2A receptors; neurodegenerative disorders; 2,8-bis(trifluoromethyl)-alpha -(3-thienyl)-4-quinolinemethanol |
06/24/2003 | US6583153 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone |
06/24/2003 | US6583145 Thio-oxindole derivatives |
06/24/2003 | US6583144 Piperazine substituted isoquinoline, 1,3-benzoxazine, or 1,3-benzothiazine derivatives; inhibitors against the biosynthesis of triglycerides and secretion of apolipoprotein b and treatment of hyperlipidemia |
06/19/2003 | WO2003050261A2 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
06/19/2003 | WO2003050109A1 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases |
06/19/2003 | WO2003050062A2 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS |
06/19/2003 | WO2003049739A1 Pyrimidine-based compounds useful as gsk-3 inhibitors |
06/19/2003 | WO2003049735A1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders |
06/19/2003 | WO2003049702A2 Vanilloid receptor ligands and their use in treatments |
06/19/2003 | WO2003005960A3 Novel bicyclic and tricyclic cannabinoids |
06/19/2003 | US20030114666 Antibacterial agents |
06/19/2003 | US20030114649 Plant fungicide |
06/19/2003 | US20030114517 Substituted urea neuropeptide Y Y5 receptor antagonists |
06/19/2003 | US20030114493 Antitumor agents |
06/19/2003 | US20030114485 Killing drug resistant cancer cells; controlling cell differentiation |
06/19/2003 | US20030114462 Drug abruse, alcoholism; respiratory system disorders, cardiovascular disorders |
06/19/2003 | US20030114455 Sexual disorders |
06/19/2003 | US20030114447 Controlling apoptosis; central nervous system disorders |
06/19/2003 | US20030114445 Bactericides |
06/19/2003 | US20030114443 Viricides, Aids therapy |
06/19/2003 | US20030114437 Protease inhibitors |
06/19/2003 | US20030114425 Tiamenidine |